Upsher-Smith Laboratories, Inc.

MAPLE GROVE, Minn., June 5, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. today announced that it is the recipient of a Distribution Industry Award for Notable Achievements in Healthcare (DIANA) given by the Healthcare Distribution Management Association (HDMA). The Company was presented with a DIANA for the ... read more

MAPLE GROVE, Minn., May 22, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. today announced the successful completion of its global Phase III clinical trial for USL255 (extended-release topiramate), an internally developed program for the management of epilepsy in adults, using the company's proprietary formulation technology. USL255 is specifically engineered to ... read more

MAPLE GROVE, Minn., May 20, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc., a specialty pharmaceutical company committed to the development of new treatments for diseases of the central nervous system, today announced the launch of its newly designed website, upsher-smith.com. The new site celebrates life's moments through ... read more

MAPLE GROVE, Minn., April 25, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith), in partnership with The Epilepsy Foundation of Minnesota (EFMN), today announced that the Pleschourt family from Dundas, Minnesota was awarded sponsorship to attend The Epilepsy Foundation's National Walk for Epilepsy(®) in Washington, D.C. on April ... read more

MAPLE GROVE, Minn., March 20, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc., (Upsher-Smith) today announced the presentation of data supporting favorable tolerability and a predictable, consistent pharmacokinetic (PK) profile of USL255 at high doses following single-dose administration to healthy subjects. USL255, an investigational once-daily, extended-release (ER) topiramate formulation is in ... read more

MAPLE GROVE, Minn., March 19, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc., (Upsher-Smith) today announced that Phase I data for USL261 (intranasal midazolam) in healthy volunteers were presented at the Annual American Academy of Neurology (AAN) Meeting in San Diego, CA. The results demonstrated that maximum midazolam plasma concentrations ... read more

MAPLE GROVE, Minn., March 11, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith), a privately held, specialty pharmaceutical company committed to the development of new treatments for diseases of the central nervous system (CNS), is proud to sponsor emerging data for three investigational drug programs in epilepsy at ... read more